IP Library Granted Patent US 8,292,807
Granted Patent B2
US 8,292,807 · App. 12/873,765 · Granted Oct 23, 2012

Mobile medical workstation

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,292,807
App. No.
12/873,765
Granted
Oct 23, 2012
Kind
B2
Abstract

A medical workstation is defined by a supporting structure having at least one medical diagnostic instrument disposed thereupon. A first display is further disposed on a first side of the supporting structure and a second display is disposed on a second side of the supporting structure in a manner substantially opposite from the first display. Each of the first and second displays are interconnected to the at least one medical diagnostic instrument to permit at least one of the displays in order to display diagnostic results and are tandemly or independently controllable.

Claims (13)

1. An integrated apparatus for use in a patient encounter, said apparatus comprising:

at least one medical diagnostic instrument including a vital signs monitoring device for measuring various physiological parameters of a patient, said physiological parameters including blood pressure, glucose, body temperature, pulse rate and blood oxygen saturation; and

a computing device connected to said at least one medical diagnostic instrument, wherein at least one of said computing device and said at least one medical diagnostic instrument are programmed to detect changes in a patient condition based on changes in two or more parameters of said patient and in which said computing device is programmed to alert the user that changes in said patient condition have exceeded at least one predetermined threshold, and

in which the changes in said at least two physiological parameters are used by said computing device to predict the onset of sepsis, wherein said computing device is programmed to calculate a glycemic control score of a patient based on historical data and to determine whether a patient's blood sugar level is within a predetermined range.

2. An integrated apparatus as recited in claim 1 , wherein said computing device is programmed to perform an independent determination as to whether the patient has had an infection.

3. An integrated apparatus as recited in claim 2 , wherein the computing device is programmed to make a further determination to whether the patient has at least two signs of Systemic Inflammatory Response Syndrome (SIRS) if the existence of a known or suspected infection has been determined.

4. An integrated apparatus as recited in claim 3 , wherein the computing device is programmed to make a determination as to whether at least one organ of the patient is failing or dysfunctional if at least two signs of SIRS have been identified.

5. An integrated apparatus for use in a patient encounter, said apparatus comprising:

at least one medical diagnostic instrument including a vital signs monitoring device for measuring various physiological parameters of a patient, said physiological parameters including blood pressure, glucose, body temperature, pulse rate and blood oxygen saturation; and

a computing device connected to said at least one medical diagnostic instrument, wherein at least one of said computing device and said at least one medical diagnostic instrument are programmed to detect changes in a patient condition based on changes in two or more parameters of said patient and in which said computing device is programmed to alert the user that changes in said patient condition have exceeded at least one predetermined threshold, and

in which the changes in said at least two physiological parameters are used by said computing device to predict the onset of sepsis, wherein said apparatus is programmed to determine a first control score based on a first parameter and a second alert score based on at least a second parameter.

6. An integrated apparatus as recited in claim 5 , wherein said first control score is based on the patient's blood sugar level.

7. An integrated apparatus as recited in claim 5 , wherein said first control score is used to determine said second alert score in which said computing device is programmed to alert a user of said apparatus if the alert score exceeds a predetermined value.

Assignments (5)
RELEASE OF SECURITY INTEREST AT REEL/FRAME 050260/0644 Recorded Dec 14, 2021
From: JPMORGAN CHASE BANK, N.A.
To: BREATHE TECHNOLOGIES, INC.; HILL-ROM SERVICES, INC.; ALLEN MEDICAL SYSTEMS, INC.; WELCH ALLYN, INC.; HILL-ROM, INC.; VOALTE, INC.; BARDY DIAGNOSTICS, INC.; HILL-ROM HOLDINGS, INC.
Reel/Frame 058517/0001 →
SECURITY AGREEMENT Recorded Sep 4, 2019
From: HILL-ROM HOLDINGS, INC.; HILL-ROM, INC.; HILL-ROM SERVICES, INC.; ALLEN MEDICAL SYSTEMS, INC.; ANODYNE MEDICAL DEVICE, INC.; VOALTE, INC.; WELCH ALLYN, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 050260/0644 →
RELEASE OF SECURITY INTEREST Recorded Sep 3, 2019
From: JPMORGAN CHASE BANK, N.A.
To: HILL-ROM SERVICES, INC.; ALLEN MEDICAL SYSTEMS, INC.; WELCH ALLYN, INC.; HILL-ROM COMPANY, INC.; HILL-ROM, INC.; ANODYNE MEDICAL DEVICE, INC.; MORTARA INSTRUMENT, INC.; MORTARA INSTRUMENT SERVICES, INC.; VOALTE, INC.
Reel/Frame 050254/0513 →
SECURITY AGREEMENT Recorded Sep 26, 2016
From: HILL-ROM SERVICES, INC.; ASPEN SURGICAL PRODUCTS, INC.; ALLEN MEDICAL SYSTEMS, INC.; WELCH ALLYN, INC.
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 040145/0445 →
SECURITY INTEREST Recorded Sep 10, 2015
From: ALLEN MEDICAL SYSTEMS, INC.; HILL-ROM SERVICES, INC.; ASPEN SURGICAL PRODUCTS, INC.; WELCH ALLYN, INC.
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 036582/0123 →